High levels of VGF are protective against the development of Alzheimer’s disease generally, and on an APOE E4 risk background there is approximately a 50% reduction in the proportion of individuals with LOAD when there are high levels of VGF (see Fig. 4, yellow box). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.